These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 3295122)

  • 21. Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
    Ramo-Tello C; Tintoré M; Rovira A; Ramió-Torrenta L; Brieva L; Saiz A; Cano A; Carmona O; Hervás JV; Grau-López L
    Mult Scler; 2016 Jan; 22(1):117-21. PubMed ID: 26540732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind controlled trial of high dose methyl prednisolone in multiple sclerosis.
    Cartier L; Verdugo R
    J Neurol Neurosurg Psychiatry; 1988 Feb; 51(2):316. PubMed ID: 3279165
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Miller AE; Wolinsky JS; Kappos L; Comi G; Freedman MS; Olsson TP; Bauer D; Benamor M; Truffinet P; O'Connor PW;
    Lancet Neurol; 2014 Oct; 13(10):977-86. PubMed ID: 25192851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-masked trial of azathioprine in multiple sclerosis. British and Dutch Multiple Sclerosis Azathioprine Trial Group.
    Lancet; 1988 Jul; 2(8604):179-83. PubMed ID: 2899660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of eye movement registration and visual evoked potentials in evaluation of therapy in patients with multiple sclerosis.
    van Dongen MM; Bertelsmann FW; Polman CH
    J Neurol Sci; 1991 Mar; 102(1):25-31. PubMed ID: 1856729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.
    Thompson AJ; Kennard C; Swash M; Summers B; Yuill GM; Shepherd DI; Roche S; Perkin GD; Loizou LA; Ferner R
    Neurology; 1989 Jul; 39(7):969-71. PubMed ID: 2544829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evoked potentials in multiple sclerosis before and after high-dose methylprednisolone infusion.
    Smith T; Zeeberg I; Sjö O
    Eur Neurol; 1986; 25(1):67-73. PubMed ID: 3940867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
    Lublin F; Miller DH; Freedman MS; Cree BAC; Wolinsky JS; Weiner H; Lubetzki C; Hartung HP; Montalban X; Uitdehaag BMJ; Merschhemke M; Li B; Putzki N; Liu FC; Häring DA; Kappos L;
    Lancet; 2016 Mar; 387(10023):1075-1084. PubMed ID: 26827074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evoked potentials with intrathecal and systemic corticosteroid therapy in multiple sclerosis].
    Heun R; Emser W; Schimrigk K
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1989 Jun; 20(2):88-91. PubMed ID: 2503359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study.
    Oliveri RL; Valentino P; Russo C; Sibilia G; Aguglia U; Bono F; Fera F; Gambardella A; Zappia M; Pardatscher K; Quattrone A
    Neurology; 1998 Jun; 50(6):1833-6. PubMed ID: 9633736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperbaric oxygen therapy in chronic stable multiple sclerosis: double-blind study.
    Harpur GD; Suke R; Bass BH; Bass MJ; Bull SB; Reese L; Noseworthy JH; Rice GP; Ebers GC
    Neurology; 1986 Jul; 36(7):988-91. PubMed ID: 3520382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.
    Martinelli V; Rocca MA; Annovazzi P; Pulizzi A; Rodegher M; Martinelli Boneschi F; Scotti R; Falini A; Sormani MP; Comi G; Filippi M
    Neurology; 2009 Dec; 73(22):1842-8. PubMed ID: 19949030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. One year follow-up.
    Bergamaschi R; Versino M; Raiola E; Citterio A; Cosi V
    Acta Neurol (Napoli); 1993 Feb; 15(1):33-43. PubMed ID: 8456594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis.
    Ozkan S; Uzuner N; Kutlu C; Ozbabalik D; Ozdemir G
    J Clin Neurosci; 2006 Feb; 13(2):214-7. PubMed ID: 16503485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.
    Brochet B; Deloire MS; Perez P; Loock T; Baschet L; Debouverie M; Pittion S; Ouallet JC; Clavelou P; de Sèze J; Collongues N; Vermersch P; Zéphir H; Castelnovo G; Labauge P; Lebrun C; Cohen M; Ruet A;
    PLoS One; 2017; 12(1):e0168834. PubMed ID: 28045953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report.
    Mertin J; Rudge P; Kremer M; Healey MJ; Knight SC; Compston A; Batchelor JR; Thompson EJ; Halliday AM; Denman M; Medawar PB
    Lancet; 1982 Aug; 2(8294):351-4. PubMed ID: 6124759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.
    Wade DT; Young CA; Chaudhuri KR; Davidson DL
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):246-9. PubMed ID: 12185153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses.
    La Mantia L; Eoli M; Milanese C; Salmaggi A; Dufour A; Torri V
    Eur Neurol; 1994; 34(4):199-203. PubMed ID: 7915989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale.
    Pascual AM; Boscá I; Coret F; Escutia M; Bernat A; Casanova B
    Eur J Neurol; 2008 Mar; 15(3):284-8. PubMed ID: 18290849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
    Lancet; 1998 Nov; 352(9139):1498-504. PubMed ID: 9820297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.